Learn more from OA expertsIs Osteoarthritis Preventable?
SD: I don't think arthritis is preventable. Previously, it was thought about being a process of wear and tear but we now know that is not quite accurate. Arthritis is actually a disease that has a certain process that involves the lining of the joint, the cartilage and the bone. And the bone actually changes, you get spurs, you get cysts and even a change in the contour. JR: ... although we cannot stop the progression of the disease we can slow that progression down through proper nutrition and diet, regular exercise, trying to maintain an ideal body weight and minimizing the trauma and impact on our knees and by keeping what we call healthy joints or healthy knees through good and proper muscular training. SD: Well, you can modify the processes that create those changes, perhaps it is and that seems to be the holy grail of the problem JR: The one thing that I would tell patients who was recently diagnosed with osteoarthritis is to understand that there are treatments available and that they need to consult their physician who takes care of their primary medical care, who may refer them to a musculoskeletal specialist to discuss all the available treatment options SD: I would also want them to know that they have to participate in their own treatment. If overweight, lose weight. If they are not exercising, exercise. If their diet is inappropriate, change their diet, but if they will contribute to their own treatment, the results of their treatment will be much, much better than if they don't.
|
|
 |
EUFLEXXA (1% sodium hyaluronate) is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy and simple analgesics (eg, acetaminophen).
Important Safety Information EUFLEXXA should not be administered through a needle previously used with medical solutions containing benzalkonium chloride. Do not use skin disinfectants for skin preparation that contain quaternary ammonium salts. Do not inject intravascularly due to potential for systemic adverse events. The safety and effectiveness of injection in conjunction with other intra-articular injectables, or into joints other than the knee have not been studied. Remove any joint effusion prior to injecting. Transient pain or swelling of the injected joint may occur after intra-articular injection with EUFLEXXA. The safety and effectiveness of repeated treatment cycles weeks with EUFLEXXA have not been established. In a randomized, double-blind, multicenter clinical trial (N=160 EUFLEXXA), the only adverse event reported with EUFLEXXA at an incidence greater than 5% was arthralgia (8.7%). Important Information for Patients. The information on this website is provided for educational purposes only. While there may be information on this web site related to certain medical conditions and their treatment, should a medical condition exist, promptly see your own physician or health provider as the information on this website is not intended to take the place of advice from a physician or healthcare professional. Ferring does not offer personalised medical diagnosis or patient-specific treatment advice. The statements made by doctors on this website represent their own individual experience and opinion and is not intended to be medical advice. Indeed, only your doctor or other health care professional, as a learned intermediary, can determine if a product described in this web site is appropriate for you. PLEASE CONSULT WITH YOUR DOCTOR, OR OTHER QUALIFIED HEALTH CARE PROFESSIONAL BEFORE USING ANY PRODUCT DISCUSSED WITHIN THIS WEB SITE. This website is intended only for US residents.  
|
 |
||||||
